contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


boule-diagnostics-renews-and-expands-a-global-supply-agreement

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Boule Diagnostics är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av diagnostiska instrument för hematologi. Bolagets produkter riktar sig till sjukvårdsinstitutioner och laboratorier. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. Boule Diagnostics grundades 1956 och har sitt huvudkontor i Spånga.

Boule Diagnostics

Clinical Diagnostics Solutions (CDS), a Boule Diagnostics company in the US, announces that its supply agreement with a leading global In Vitro Diagnostics (IVD) customer has been renewed and...

<div class="mfn-body"><p>Clinical Diagnostics Solutions (CDS), a Boule Diagnostics company in the US, announces that its supply agreement with a leading global In Vitro Diagnostics (IVD) customer has been renewed and expanded. The extended agreement is a result of the trust in CDS and the work to innovate for diagnostic technologies worldwide.<br>&nbsp;<br>The agreement is expected to increase sales by approximately SEK 5 million once the project is fully implemented in 2027 and have a good operating margin. This expansion strengthens Boule's strategic focus on long-term partnerships and profitable growth. <em>"This agreement underlines the confidence in CDS's solutions and strengthens our role in advancing health diagnostics globally,"</em> says Torben Nielsen, CEO of Boule Diagnostics. <em>“We look forward to continuing to deliver value and be a trusted supplier to our partners."</em></p></div><div class="mfn-footer mfn-contacts mfn-5bb0e13f66bc"><p><strong class="mfn-heading-1">Contacts</strong><br>Torben Nielsen, CEO and Group President, <a rel="noopener" href="mailto:torben.nielsen@boule.com">torben.nielsen@boule.com</a>, phone +46 (0)70-558 51 05<br>Holger Lembrér, CFO, <a rel="noopener" href="mailto:holger.lembrer@boule.com">holger.lembrer@boule.com</a>, phone +46 (0)72-230 77 10<br></p></div><div class="mfn-footer mfn-about mfn-ac6499eab38b"><p><strong class="mfn-heading-1">About Us</strong><br>Boule Diagnostics AB (publ) is a global company consisting of two business segments, Diagnostics and OEM CDS. Diagnostics is specialized in near-patient, decentralized diagnostic solutions for human and veterinary applications, serving hospitals, clinics, laboratories. OEM CDS develops and delivers reliable reagent, blood controls and calibrators tailored for diagnostic companies worldwide. <br>With operations in Sweden, the United States, Mexico, and Russia, and a global distribution network spanning more than 100 countries, Boule combines a resilient business model with strong positions in key growth markets. In 2024, Boule reported net sales of SEK 558 million and has about 200 employees worldwide. Boule has been listed on Nasdaq Stockholm since 2011. <a rel="noopener" href="http://www.boule.com/">http://www.boule.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/29a53bf6-a6e7-42a8-b8d9-41b98a27ce8f/boule-diagnostics-renews-and-expands-a-global-supply-agreement.pdf" class="mfn-generated mfn-primary">Boule Diagnostics Renews and Expands a Global Supply Agreement</a></p></div>